Lenacapavir scale-up: a window to strengthen sexually transmitted infection services
- 12 October 2026
- journal article
- letter
- Published by Springer Nature in Journal of Public Health Policy
- p. 1-4
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse PersonsNew England Journal of Medicine, 2025
- Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender WomenNew England Journal of Medicine, 2024
- Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted InfectionsNew England Journal of Medicine, 2023
- Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2018